Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
American PAPR is a private U.S. medical device and personal protective equipment company that manufactures NIOSH-certified powered air-purifying respirators for healthcare and industrial users. The company was founded in 2020 in response to frontline demand during the COVID-19 era and operates as a domestic manufacturer with production in New York. Its lead commercial products are the FELIX100 and FELIX200 PAPR systems, designed to provide reusable, high-efficiency particulate respiratory protection without fit testing for loose-fitting configurations. American PAPR emphasizes U.S.-based manufacturing, quality-system-driven production, and reusable respiratory protection intended to offer an alternative to disposable N95 masks in clinical and industrial settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American PAPR.